Reimbursed with a limitationOriginator productATC L01AA09

Ribomustin

Ribomustin is an originator product from CPS Cito Pharma Services GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 79.20 to CHF 277.35 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
CPS Cito Pharma Services GmbH
ATC code
L01AA09
IT group
07.16.10 Cytostatica
Active substances
Bendamustini hydrochloridum
Preparation type
Originator product
On the SL since
01/11/2009
Last price change
01/12/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Ribomustin Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 25 mgDurchstf 1 StkCHF 58.04CHF 79.2001/11/2009A7680588160063
Trockensub 25 mgDurchstf 5 StkCHF 241.17CHF 277.3501/11/2009A7680588160018
Trockensub 100 mgDurchstf 1 StkCHF 187.85CHF 219.6501/11/2009A7680588160049

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/11/2009

Therapie der chronisch-lymphatischen Leukämie (CLL) vom B-Zell-Typ. Die Firstline-Therapie mit RIBOMUSTIN sollte nur bei Patienten mit fortgeschrittener Erkrankung begonnen werden, d.h. im Binet-Stadium B oder C, einhergehend mit krankheitsbedingten Symptomen oder Zeichen einer Krankheitsprogression.

FOPH wordingValid from 01/02/2013

In der Erstlinientherapie des follikulären Non-Hodgkin-Lymphom in Kombination mit Rituximab für maximal 6 Zyklen.
Bei Patienten mit Progression des Follikulären Non-Hodgkin-Lymphom während oder innerhalb von 6 Monaten nach Behandlung mit Rituximab oder einer Rituximab-enthaltenden Therapie.

More preparations in this group

FAQ

Is Ribomustin covered by Swiss health insurance?

Yes, but only under conditions. Ribomustin is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Ribomustin cost in Switzerland?

The public price is the maximum price set by the FOPH and for Ribomustin ranges from CHF 79.20 to CHF 277.35 per pack. The ex-factory price ranges from CHF 58.04 to CHF 241.17. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com